Publications by authors named "Ann Behrens"

Claim this Profile
O
Orbital Atherectomy for Treatment of Complex Severely Calcified Coronary Artery Lesions: Insights from a Veterans Affairs Cohort.
Robert Sturm, Brad J Martinsen, Javier A Valle, Stephen W Waldo, Ann N Behrens

Cardiovasc Revasc Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Year Outcomes of Peripheral Endovascular Device Intervention in Critical Limb Ischemia Patients: Sub-Analysis of the LIBERTY 360 Study.
Jihad A Mustapha, Zsuzsanna Igyarto, David O'Connor, Ehrin J Armstrong, Anthony R Iorio, Ann N Behrens

Vasc Health Risk Manag· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orbital Atherectomy for the Treatment of Long (≥25-40 mm) Severely Calcified Coronary Lesions: ORBIT II Sub-Analysis.
Gautam Kumar, Eric Youngyoon Shin, Rajesh Sachdeva, Evan Shlofmitz, Ann N Behrens

Cardiovasc Revasc Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after Atherectomy Treatment of Severely Calcified Coronary Bifurcation Lesions: A Single Center Experience.
Jeffrey W Chambers, Charles Warner, Josh Cortez, Ann N Behrens, Dylan T Wrede

Cardiovasc Revasc Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Procedural and Long-Term Ischemic Outcomes of Tight Subtotal Occlusions Treated with Orbital Atherectomy: An ORBIT II Subanalysis.
Michael S Lee, Richard A Shlofmitz, Evan Shlofmitz, Ann N Behrens, George Revtyak

Cardiovasc Revasc Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Stenting in Patients Treated with Orbital Atherectomy: An ORBIT II Subanalysis.
Evan Shlofmitz, Brad J Martinsen, Ann N Behrens, Ziad A Ali, Michael S Lee

Cardiovasc Revasc Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orbital atherectomy for calcified femoropopliteal lesions: a current review.
Fadi Saab, Brad J Martinsen, Dylan Wrede, Ann Behrens, George L Adams

J Cardiovasc Surg (Torino)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute outcomes after coronary orbital atherectomy at a single center without on-site surgical backup: An experience in diabetics versus non-diabetics.
Matthew G Whitbeck, James Dewar, Ann N Behrens, Jeffrey Watkins, Brad J Martinsen

Cardiovasc Revasc Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of diabetes mellitus on procedural and one year clinical outcomes following treatment of severely calcified coronary lesions with the orbital atherectomy system: A subanalysis of the ORBIT II study.
Michael S Lee, Brad J Martinsen, Arthur C Lee, Ann N Behrens, Richard A Shlofmitz

Catheter Cardiovasc Interv· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing intravascular ultrasound imaging prior to treatment of severely calcified coronary lesions with orbital atherectomy: An ORBIT II sub-analysis.
Evan Shlofmitz, Brad Martinsen, Michael Lee, Philippe Généreux, Ann Behrens

J Interv Cardiol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atherectomy Devices for the Treatment of Calcified Coronary Lesions.
Jeffrey W Chambers, Ann N Behrens, Brad J Martinsen

Interv Cardiol Clin· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sox7 is regulated by ETV2 during cardiovascular development.
Ann N Behrens, Claudia Zierold, Xiaozhong Shi, Yi Ren, Naoko Koyano-Nakagawa

Stem Cells Dev· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nkx2-5 mediates differential cardiac differentiation through interaction with Hoxa10.
Ann N Behrens, Michelina Iacovino, Jamie L Lohr, Yi Ren, Claudia Zierold

Stem Cells Dev· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nkx2-5 Regulates Tdgf1 (Cripto) Early During Cardiac Development.
Ann N Behrens, Yi Ren, Anwarul Ferdous, Daniel J Garry, Cindy M Martin

J Clin Exp Cardiolog· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis